We are live on ! Find out more
WCM

Westend Capital Management Portfolio holdings

AUM $333M
1-Year Est. Return 86.16%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+86.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$343M
AUM Growth
+$18.6M
Cap. Flow
-$12.3M
Cap. Flow %
-3.59%
Top 10 Hldgs %
58.35%
Holding
279
New
51
Increased
46
Reduced
18
Closed
25

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.2M
2
BABA icon
Alibaba
BABA
+$16.3M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$7.85M
4
BIDU icon
Baidu
BIDU
+$7.48M
5
BA icon
Boeing
BA
+$2.55M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$13.1M
2
INTU icon
Intuit
INTU
+$10.9M
3
FCX icon
Freeport-McMoran
FCX
+$9.95M
4
VEEV icon
Veeva Systems
VEEV
+$8.08M
5
NTR icon
Nutrien
NTR
+$7.09M

Sector Composition

Rank Sector Weight
1 Industrials 26.82%
2 Technology 19.33%
3 Communication Services 15.7%
4 Consumer Discretionary 14.97%
5 Financials 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
101
Walmart Inc
WMT
$888B
$21.4K 0.01%
208
+68
+49% +$6.77K
CL icon
102
Colgate-Palmolive
CL
$71.6B
$21.3K 0.01%
266
ESML icon
103
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.93B
$21.1K 0.01%
467
IEMG icon
104
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$20.6K 0.01%
+313
New +$19.5K
PEP icon
105
PepsiCo
PEP
$190B
$20.5K 0.01%
146
-69
-32% -$9.85K
DAVE icon
106
Dave Inc
DAVE
$5.07B
$19.9K 0.01%
+100
New +$21.6K
ADP icon
107
Automatic Data Processing
ADP
$107B
$18.8K 0.01%
64
AZN icon
108
AstraZeneca
AZN
$245B
$18K 0.01%
117
+39
+50% +$5.9K
SPMO icon
109
Invesco S&P 500 Momentum ETF
SPMO
$22.1B
$17.7K 0.01%
146
PG icon
110
Procter & Gamble
PG
$345B
$16.6K ﹤0.01%
108
RIO icon
111
Rio Tinto
RIO
$161B
$16.5K ﹤0.01%
250
DE icon
112
Deere & Co
DE
$163B
$16.5K ﹤0.01%
36
+10
+38% +$4.93K
LOW icon
113
Lowe's Companies
LOW
$122B
$15.6K ﹤0.01%
62
BNY
114
Bank of New York Mellon
BNY
$106B
$15.4K ﹤0.01%
141
STRL icon
115
Sterling Infrastructure
STRL
$16.6B
$14.9K ﹤0.01%
44
SO icon
116
Southern Company
SO
$107B
$14.8K ﹤0.01%
156
USB icon
117
US Bancorp
USB
$99.6B
$14.5K ﹤0.01%
300
DLY
118
DoubleLine Yield Opportunities Fund
DLY
$682M
$14.4K ﹤0.01%
953
-12,854
-93% -$198K
IONQ icon
119
IonQ
IONQ
$15.6B
$13.8K ﹤0.01%
+224
New +$10.5K
MS icon
120
Morgan Stanley
MS
$332B
$13.4K ﹤0.01%
84
+37
+79% +$5.46K
VEU icon
121
Vanguard FTSE All-World ex-US ETF
VEU
$68B
$13.2K ﹤0.01%
+185
New +$12.8K
LMT icon
122
Lockheed Martin
LMT
$135B
$13K ﹤0.01%
26
GD icon
123
General Dynamics
GD
$103B
$13K ﹤0.01%
38
SAP icon
124
SAP
SAP
$226B
$12.8K ﹤0.01%
+48
New +$13.5K
NVS icon
125
Novartis
NVS
$292B
$12.8K ﹤0.01%
100

Similar funds

Westend Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Westend Capital Management held 279 positions worth $343M, up 5.7% from $325M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Westend Capital Management withdrew a net $12.3M in Q3 2025, closing 25 positions and reducing 18 holdings. Its most notable exit was Intuitive Surgical, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 25% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Westend Capital Management opened a new position in Baidu worth $9.96M.

  • Westend Capital Management's largest Q3 2025 buy was Baidu: 75,562 shares worth $9.96M.
  • Westend Capital Management added most to Apple in Q3 2025, an estimated $17.2M increase.
  • Westend Capital Management's biggest Q3 2025 reduction was Freeport-McMoran, cutting an estimated $9.95M.
  • Westend Capital Management fully exited Intuitive Surgical in Q3 2025, selling an estimated $13.1M.
  • Westend Capital Management's ten largest holdings make up 58% of its $343M portfolio in Q3 2025.
  • Westend Capital Management opened 51 new positions and closed 25 in Q3 2025.
  • Westend Capital Management's portfolio value rose 5.7% quarter-over-quarter to $343M.

Based on Westend Capital Management's 13F filing for Q3 2025, filed 17 Oct 2025.